Publications by authors named "Graham M Mead"

Claim this Profile
R
Randomized phase III study comparing paclitaxel/cisplatin/gemcitabine and gemcitabine/cisplatin in patients with locally advanced or metastatic urothelial cancer without prior systemic therapy: EORTC Intergroup Study 30987.
Joaquim Bellmunt, Hans von der Maase, Graham M Mead, Iwona Skoneczna, Maria De Santis

J Clin Oncol· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The clinical features and management of testicular germ cell tumours in patients aged 60 years and older.
Matthew J Wheater, James Manners, Luke Nolan, Peter D Simmonds, Matthew C Hayes, Graham M Mead

BJU Int· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized trial of carboplatin versus radiotherapy for stage I seminoma: mature results on relapse and contralateral testis cancer rates in MRC TE19/EORTC 30982 study (ISRCTN27163214).
R Timothy D Oliver, Graham M Mead, Gordon J S Rustin, Johnathan K Joffe, Nina Aass

J Clin Oncol· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized trials in 2466 patients with stage I seminoma: patterns of relapse and follow-up.
Graham M Mead, Sophie D Fossa, R Timothy D Oliver, Johnathan K Joffe, Robert A Huddart

J Natl Cancer Inst· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective clinicopathologic study of dose-modified CODOX-M/IVAC in patients with sporadic Burkitt lymphoma defined using cytogenetic and immunophenotypic criteria (MRC/NCRI LY10 trial).
Graham M Mead, Sharon L Barrans, Wendi Qian, Jan Walewski, John A Radford

Blood· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part II.
Susanne Krege, Jörg Beyer, Rainer Souchon, Peter Albers, Walter Albrecht, Graham M Mead

Eur Urol· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I.
Susanne Krege, Jörg Beyer, Rainer Souchon, Peter Albers, Walter Albrecht, Graham M Mead

Eur Urol· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intestinal strictures: a new complication of treatment for primary gastrointestinal diffuse large B-cell lymphoma.
Jonathan P Kerr, Mandy Turner, Margaret Ashton-Key, Graham M Mead, Peter W M Johnson

Br J Haematol· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant factor VIIa in the management of pulmonary hemorrhage associated with metastatic choriocarcinoma.
Matthew J Wheater, Graham M Mead, Sandeep Bhandari, Jonathan Fennell

J Clin Oncol· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
18fluorodeoxyglucose positron emission tomography in the prediction of relapse in patients with high-risk, clinical stage I nonseminomatous germ cell tumors: preliminary report of MRC Trial TE22--the NCRI Testis Tumour Clinical Study Group.
Robert A Huddart, Michael J O'Doherty, Anwar Padhani, Gordon J S Rustin, Graham M Mead

J Clin Oncol· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized trial of two or five computed tomography scans in the surveillance of patients with stage I nonseminomatous germ cell tumors of the testis: Medical Research Council Trial TE08, ISRCTN56475197--the National Cancer Research Institute Testis Cancer Clinical Studies Group.
Gordon J Rustin, Graham M Mead, Sally P Stenning, Paul A Vasey, Nina Aass

J Clin Oncol· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized trial of 30 versus 20 Gy in the adjuvant treatment of stage I Testicular Seminoma: a report on Medical Research Council Trial TE18, European Organisation for the Research and Treatment of Cancer Trial 30942 (ISRCTN18525328).
William G Jones, Sophie D Fossa, Graham M Mead, J Trevor Roberts, Michael Sokal

J Clin Oncol· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of the nonsurgical oncologist in the management of advanced transitional cell cancer. Part I: locally advanced disease.
Graham M Mead, J Trevor Roberts

BJU Int· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of the nonsurgical oncologist in the management of advanced transitional cell cancer. Part II: metastatic disease.
Graham M Mead, J Trevor Roberts

BJU Int· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life in good prognosis patients with metastatic germ cell cancer: a prospective study of the European Organization for Research and Treatment of Cancer Genitourinary Group/Medical Research Council Testicular Cancer Study Group (30941/TE20).
Sophie D Fosså, Ronald de Wit, J Trevor Roberts, Peter M Wilkinson, Pieter H M de Mulder, Graham M Mead

J Clin Oncol· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis